Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies

被引：3

作者：

Einsele, Hermann ^{[1
]}

Briones, Javier ^{[2
]}

Ciceri, Fabio ^{[3
,4
]}

Garcia-Cadenas, Irene ^{[2
]}

Falkenburg, Fred ^{[5
]}

Bolanos, Natacha ^{[6
]}

Heemskerk, H. M. Mirjam ^{[5
]}

Houot, Roch ^{[7
,8
]}

Hudecek, Michael ^{[1
]}

Locatelli, Franco ^{[9
]}

Morgan, Kate ^{[10
]}

Morris, C. Emma ^{[11
]}

O'Dwyer, Michael ^{[12
,13
]}

Gil, Jordi Sierra ^{[2
,14
,15
]}

van den Brink, Marcel ^{[16
]}

van de Loosdrecht, Arjan A. ^{[17
]}

机构：

[1] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany

[2] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[3] Univ Vita Salute San Raffaele, Milan, Italy

[4] IRCCS San Raffaele Sci Inst, Div Transplantat Immunol & Transplantat Dis, Milan, Italy

[5] Leiden Univ Med Ctr, Dept Hematol, Leiden, Netherlands

[6] Lymphoma Coalit Europe, Madrid, Spain

[7] Univ Rennes, CHU Rennes, INSERM U1236, Rennes, France

[8] Dana Farber Canc Inst, Boston, MA 02115 USA

[9] Sapienza Univ Rome, Bambino Gesu Childrens Hosp, IRCCS, Rome, Italy

[10] Myeloma UK, Edinburgh, Midlothian, Scotland

[11] Royal Free Hosp, UCL Inst Immun & Transplantat, London, England

[12] Univ Hosp Galway, Dept Haematol, Galway, Ireland

[13] Natl Univ Ireland, Galway, Ireland

[14] St Pau Biomed Res Inst, Barcelona, Spain

[15] Jose Carreras Leukemia Res Inst, Barcelona, Spain

[16] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[17] Vrije Univ Amsterdam Med Ctr, Amsterdam UMC, Amsterdam, Netherlands

来源：

HEMASPHERE | 2020年 / 4卷 / 04期

关键词：

MINOR HISTOCOMPATIBILITY ANTIGENS; DELTA-T-CELLS; MONOCLONAL-ANTIBODIES; CHECKPOINT INHIBITION; THERAPEUTIC VACCINES; CANCER-IMMUNOTHERAPY; CMV INFECTION; PD-1; BLOCKADE; STEM-CELL; LEUKEMIA;

D O I：

10.1097/HS9.0000000000000423

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：5

共 50 条

[1] The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
Einsele, Hermann
Briones, Javier
Ciceri, Fabio
Garcia Cadenas, Irene
Falkenburg, Fred
Bolanos, Natacha
Heemskerk, H. M. Mirjam
Houot, Roch
Hudecek, Michael
Locatelli, Franco
Morgan, Kate
Morris, Emma C.
O'Dwyer, Michael
Sierra, Jordi Gil
van den Brink, Marcel
van de Loosdrecht, Arjan A.
[J]. HEMASPHERE, 2021, 5 (10):
[2] Advances in immune therapies in hematological malignancies
Mazzarella, Luca
Enblad, Gunilla
Olweus, Johanna
Malmberg, Karl-Johan
Jerkeman, Mats
[J]. JOURNAL OF INTERNAL MEDICINE, 2022, 292 (02) : 205 - 220
[3] Immune recognition and immunotherapy in hematological malignancies
Orsini, E
Guarini, A
Torelli, G
Foá, R
[J]. MINERVA BIOTECNOLOGICA, 1999, 11 (04) : 325 - 334
[4] Apoptosis-based therapies for hematological malignancies
Petronelli, A
Riccioni, R
Pasquini, L
Petrucci, E
Testa, U
[J]. DRUGS OF THE FUTURE, 2005, 30 (07) : 707 - 723
[5] DC-based immunotherapy for hematological malignancies
Kitawaki, Toshio
[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (02) : 117 - 122
[6] DC-based immunotherapy for hematological malignancies
Toshio Kitawaki
[J]. International Journal of Hematology, 2014, 99 : 117 - 122
[7] Overview of Antiangiogenic Therapies in Hematological Malignancies
Ribatti, D.
[J]. CURRENT CANCER DRUG TARGETS, 2011, 11 (09) : 995 - 996
[8] Epigenetic abnormalities and therapies for hematological malignancies
Toshio Kitamura
[J]. International Journal of Hematology, 2019, 110 : 147 - 149
[9] Epigenetic abnormalities and therapies for hematological malignancies
Kitamura, Toshio
[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (02) : 147 - 149
[10] Cellular immunotherapy for refractory hematological malignancies
John L Reagan
Loren D Fast
Howard Safran
Martha Nevola
Eric S Winer
Jorge J Castillo
James N Butera
Matthew I Quesenberry
Carolyn T Young
Peter J Quesenberry
[J]. Journal of Translational Medicine, 11

← 1 2 3 4 5 →